Massachusetts General Hospital

Stories

NIH awards Mass General $8.3 million to expand access to experimental ALS drug

As of September 2026: Award recipient and EAP operator

The National Institutes of Health (NIH) awarded $8.3 million to Massachusetts General Hospital to run a program giving ALS patients access to an experimental drug they can't get through clinical trials. The program, called an intermediate-size expanded access protocol (EAP), begins September 1.

Updated Sep 17